ACCURNA
AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.
ACCURNA
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2015-12-01
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.accurna.com
Total Employee:
11+
Status:
Active
Contact:
+81-3-5803-2862
Email Addresses:
[email protected]
Total Funding:
770.25 M JPY
Technology used in webpage:
Google Maps Japanese Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-09-30 | NanoCarrier Co | NanoCarrier Co acquired by AccuRna | N/A |
Investors List
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - AccuRna
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - AccuRna
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - AccuRna
SMBC Venture Capital
SMBC Venture Capital investment in Series B - AccuRna
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - AccuRna
NanoCarrier Co
NanoCarrier Co investment in Series B - AccuRna
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Seed Round - AccuRna
Official Site Inspections
http://www.accurna.com
- Host name: www9.gmoserver.jp
- IP address: 160.251.229.1
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "AccuRna"
AccuRna - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +81-3-5803-2862 AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS …See details»
AccuRna 2025 Company Profile: Valuation, Investors, Acquisition
AccuRna General Information Description. Developer of drug delivery systems designed for nucleic acid therapeutics. The company's drug delivery system has two platforms for both …See details»
AccuRna Company Profile | Management and Employees List
AccuRna Profile and History. AccuRna Inc. has established in December 2015 with a mission to achieve the practical use of the "RNA delivery system", which is the research result of Prof. …See details»
AccuRna - Headquarter Location, Corporate Office Address and …
AccuRna is Drug Delivery in Japan that focus on drug delivery system business. Founded in 2015. They cover business area such as developer, drug delivery system, nucleic acid …See details»
AccuRna - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 8, 2025 AccuRna. has raised a total funding of $5.06M over 1 round. What are the most recent funding rounds of AccuRna? Its latest funding round was a Seed round on Jan 17, …See details»
About us – AccuRna, Inc.
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug. Our aim is to promote therapeutic innovation in …See details»
AccuRna Company Profile - Office Locations, Competitors ... - Craft
AccuRna has 1 employees across 2 locations and $6.5 m in total funding,. See insights on AccuRna including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
AccuRna - Funding, Financials, Valuation & Investors - Crunchbase
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain. New. Resources. Advanced Search. ... How much funding has this …See details»
Management team – AccuRna, Inc.
Hiromichi Kimura, Ph.D. Director After working at the pharmaceutical division of Kyowa Hakko Kogyo and J.P. Morgan as Vice President, Mergers & Acquisitions Division, Dr. Kimura …See details»
AccuRna - Crunchbase
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain. New. Resources. Advanced Search. Start Free Trial . Talk With …See details»
Quick Facts – AccuRna, Inc.
Fast Track Initiative, Inc. UTokyo Innovation Platform Co., Ltd. SMBC Venture Capital Co., Ltd. NanoCarrier Co., Ltd.See details»
AccuRna Closes Additional Financing Round – AccuRna, Inc.
Dec 23, 2019 AccuRna Inc. (CEO: Shiro Akinaga, Ph.D., “AccuRna”) today announced the completion of an additional financing round led by UTokyo Innovation Platform Co., Ltd. and …See details»
AccuRna, Inc. - VentureRadar
Open PageRank: 9,963,277 | accurna.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of …See details»
AccuRna - Products, Competitors, Financials, Employees, …
About AccuRna. AccuRna is a biotech company that specializes in nucleic acid therapeutics with a focus on drug delivery systems. The company develops a robust drug delivery system for …See details»
AccuRna - Overview, News & Similar companies | ZoomInfo.com
Mar 6, 2018 Who is AccuRna. AccuRna Inc. has established in December 2015 with a mission to achieve the practical use of the "RNA delivery system", which is the research resul t of Prof. …See details»
FTI設立出資先のアキュルナ株式会社がナノキャリア株式会社と合 …
Sep 1, 2020 会社名：アキュルナ株式会社／AccuRna, Inc. 設立：2015年10月 代表取締役社長 秋永 士郎 会社所在地：東京都文京区本郷3丁目42−1 湯島三友ビル 事業概要：オリゴ核酸 …See details»
AccuRna - Raised $5.06M Funding from 4 investors - Tracxn
Mar 23, 2025 AccuRna has raised a total funding of $5.06M over 1 round from 4 investors. Investors include SMBC Venture Capital, Fast Track Initiative and 2 others. Their latest …See details»
AccuRna - Contacts, Employees, Board Members, Advisors & Alumni
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.See details»
AccuRna - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. AccuRna . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. AccuRna is …See details»
Cancer biotech Inspirna winding down
2 days ago The biotech had drugs in early to midstage testing in the forms of CKB/SLC6A8 pathway-targeted RGX-202, also known as ompenaclid, in gastrointestinal (GI) cancers and …See details»